Crossmark

Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy

Crossref DOI link: https://doi.org/10.1016/j.eimc.2020.06.002

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Parra-Millán, Raquel

Jiménez-Mejías, Manuel E.

Ayerbe-Algaba, Rafael

Domínguez-Herrera, Juan

Díaz, Caridad

Pérez del Palacio, José

Pachón, Jerónimo

Smani, Younes
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III, Proyectos de Investigación en Salud (PI13/01744, PI16/01306)

Consejería de Innovación, Ciencia y Empresa (P11-CTS-6317)

Fundación MEDINA
License Information

Text and Data Mining valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2020.06.002

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Document is current

Any future updates will be listed below